CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
NeuroProtect aims to prevent chemotherapy-induced peripheral neuropathy by applying Localised Microvascular Compression Therapy. This technique reduces blood flow to nerve fibers during chemotherapy, minimizing damage and preserving neural function, thus improving patients' quality of life.
Chemotherapy induced peripheral neuropathy (CIPN) is a debilitating neural condition that affects millions of European cancer patients every year.
It is considered by patients and oncologists to be the most significant long-term impact of cancer treatment and often results in devastating consequences for patients, including an inability to work or perform the basic tasks of daily living.
With chemotherapy usage set to increase by 53% by 2040, CIPN remains a clear and urgent unmet patient need. C…
UNIVERSITY OF GALWAY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
